Latest Company News

Qubot Technology has raised nearly RMB 100 million in a Pre-A+ round to advance Maxwell, its neurointerventional robotic platform combining magnetic distal-tip guidewire control, 4D-DSA imaging and a VLA foundation model, with the long-term goal of automated mechanical thrombectomy.

WEISEBOT is expanding its laparoscopic surgical robotics platform around procedure-specific clinical needs, with new developments in energy instruments, bipolar sealing, extended curved scissors and system integration aimed at supporting more complex general surgery workflows.

From high-end imaging and cardiovascular implants to diagnostics and surgical robotics, Chinese MedTech companies are moving rapidly up the value chain—and increasingly into global markets. This guide profiles 20 companies international executives should know, outlining what they make, where they compete and why they matter in 2026.

TIROMU raised tens of millions of RMB in Pre-A funding to advance clinical trials and registration filing for its fundus injection surgical robot, while continuing R&D on next-generation ophthalmic microsurgery systems.